BMSCs not only participate in the repair of neurological function of ischemic brain injury, but also serve as a carrier for gene therapy of cerebral ischemia, while whether overexpression of XIAP in BMSCs can prevent apoptosis in vitro remains to be unearthed, which could be verified in future study if condition permitting (Additional file 1). This evidence concerns the gene XIAP and Cerebral ischemia.